In vitro immune modulation by antibodies coupled to tumour cells.

In vitro immune modulation by antibodies coupled to tumour cells.

Modification of autologous tumour cells to express the immune costimulator B7.1 is a potential strategy for immunotherapy of cancer. Previously, this has involved introduction of genetic material into cells, in vitro culture, and confirmation of the protein product on the cell surface. This is possi...

Bibliográfalaš dieđut
Váldodahkkit:	Darling, D, Galea-Lauri, J, Gäken, J, Towner, P, Kuiper, M, Hollingsworth, S, Hirst, W, Barnard, A, Buggins, A, Mufti, G, Farzaneh, F
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1997

Geahča maid

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
Dahkki: Gaken, J, et al.
Almmustuhtton: (1997)

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
Dahkki: Hirst, W, et al.
Almmustuhtton: (1996)

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Dahkki: Gaken, J, et al.
Almmustuhtton: (1997)

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
Dahkki: GaleaLauri, J, et al.
Almmustuhtton: (1996)

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Dahkki: Chan, L, et al.
Almmustuhtton: (2006)

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.
Dahkki: Kuiper, M, et al.
Almmustuhtton: (1996)

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
Dahkki: Darling, D, et al.
Almmustuhtton: (2000)

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML
Dahkki: Chan, L, et al.
Almmustuhtton: (2004)

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Dahkki: Chan, L, et al.
Almmustuhtton: (2005)

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (1999)

Novel costimulators in the immune gene therapy of cancer.
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (1996)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (2001)

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.
Dahkki: Chan, L, et al.
Almmustuhtton: (2005)

Prospects of immune gene therapy for cancer
Dahkki: Hardwick, N, et al.
Almmustuhtton: (2004)

Monocistronic high titre vectors for targeted expression of multiple therapeutic genes
Dahkki: Darling, D, et al.
Almmustuhtton: (2004)

High titre vectors for targeted expression of multiple genes
Dahkki: Darling, D, et al.
Almmustuhtton: (2004)

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (2002)

Fusagene vectors: A novel strategy for the expression of multiple genes from a single cistron
Dahkki: Gaken, J, et al.
Almmustuhtton: (1998)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
Dahkki: Gäken, J, et al.
Almmustuhtton: (2000)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
Dahkki: Gaken, J, et al.
Almmustuhtton: (2001)

Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
Dahkki: Wells, J, et al.
Almmustuhtton: (2005)

Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
Dahkki: Hughes, C, et al.
Almmustuhtton: (2001)

Characterization of monoclonal antibodies against rabbit CD44: evidence of a role for CD44 in modulating synoviocyte metabolism.
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (1993)

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (2004)

A comparison of CTL induction by different methods of antigen loading of monocyte-derived dendritic cells
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (2001)

Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.
Dahkki: Gäken, J, et al.
Almmustuhtton: (1996)

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
Dahkki: Wells, J, et al.
Almmustuhtton: (2007)

Affinity mediated magnetic concentration of retroviral vectors
Dahkki: Hughes, C, et al.
Almmustuhtton: (2001)

Identification and tissue distribution of rabbit leucocyte antigens recognized by monoclonal antibodies.
Dahkki: Wilkinson, J, et al.
Almmustuhtton: (1992)

The expression of CD11/CD18 molecules on rabbit leucocytes: identification of monoclonal antibodies to CD18 and their effect on cellular adhesion processes.
Dahkki: Galea-Lauri, J, et al.
Almmustuhtton: (1993)

Cloning and Characterization of a Retroviral Plasmid, pCC1, for Combination Suicide Gene Therapy
Dahkki: Marcel Kuiper, et al.
Almmustuhtton: (2000-03-01)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Dahkki: Pedro Marques, et al.
Almmustuhtton: (2019-11-01)

Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with CAMPATH-1H.
Dahkki: Buggins, A, et al.
Almmustuhtton: (2001)

Engineering antibodies to study and improve immunomagnetic isolation of tumour cells
Dahkki: Jain, J
Almmustuhtton: (2013)

Immunological weapons against acute myeloid leukaemia.
Dahkki: Galea-Lauri, J
Almmustuhtton: (2002)

Antibody-Based Approaches to Target Pancreatic Tumours
Dahkki: Marie Sorbara, et al.
Almmustuhtton: (2022-07-01)

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma
Dahkki: Daniels, H, et al.
Almmustuhtton: (2005)

Fructose modulates cardiomyocyte excitation-contraction coupling and Ca²⁺ handling in vitro.
Dahkki: Kimberley M Mellor, et al.
Almmustuhtton: (2011-01-01)

In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity
Dahkki: Nicholas C. Wu, et al.
Almmustuhtton: (2017-05-01)

The In Vitro Stability of Circulating Tumour DNA.
Dahkki: Emanuela Henao Diaz, et al.
Almmustuhtton: (2016-01-01)